Women are more susceptible to certain diseases such as menstrual disorders, cancer, osteoporosis, sexual disorders, and autoimmune diseases. The major diseases include cervical cancer, breast cancer, infertility, menopause, and polycystic ovarian syndrome (PCOS). As per the Centers for Disease Control and Prevention, PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of US women of reproductive age.
The demand for Women's Health Diagnostics is mainly increasing on account of the increasing incidence of chronic and lifestyle disorders, rising awareness regarding various health-related disorders, high prevalence of infectious diseases such as hepatitis and HIV in women all over the world. Moreover, the rising number of diagnostic and imaging centers and the high adoption of POC diagnostic testing also propel market growth. As per the Joint United Nations Program on HIV and AIDS 2020, women and girls accounted for about 50% of all new HIV infections in 2020 while in sub-Saharan Africa, women and girls accounted for 63% of all new HIV infections.
Some of the major players operating in the market include Abbott Laboratories, Becton, Dickinson, and Company, Biomerieux SA, Carestream Health, Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mankind Pharma, and Siemens AG. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Insights Presented in the Report
“Amongst Applications, Breast Cancer Testing segment holds the major share.”
Based on Applications, the market is fragmented into Breast Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, and Prenatal Testing. Breast Cancer Testing holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to increasing breast cancer cases and rising awareness about advanced breast cancer diagnostic techniques, such as Automated Breast Ultrasonography (ABUS) which allows three-dimensional representation of breast tissue and allows images reformatting in 3D. Moreover, women suffering from breast cancer are more prone to getting affected by the COVID-19 infection. As per breastcancer.org, approximately 281,550 new cases of invasive breast cancer and 49,290 new cases of non-invasive (in situ) breast cancer are estimated to be diagnosed in women in the U.S. in 2021.
“Amongst End-user, Homecare is anticipated to grow at the highest CAGR during the analyzed period.”
Based on End-user, the market is fragmented into Diagnostics Centers, Hospitals, and Homecare. The home care segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period due to the rising incidents of infectious diseases which has resulted in increased use of self-testing kits. The self-testing kits allow the patients to manage their diseases by utilizing these kits. Furthermore, Technological advancements have made many self-testing kits available for various conditions, such as pregnancy and ovulation. For instance, the Prega News Pregnancy Kit developed by Mankind Pharmaceuticals Ltd uses a sera reagent that will detect Human chorionic gonadotropin (HCG) content in a woman’s urine, signifying whether a woman is pregnant or not remotely.
“North America signifies one of the largest markets and Europe is expected to be the fastest-growing markets of Women Health Diagnostics market.”
For a better understanding of the market adoption of Women Health Diagnostics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Women Health Diagnostics market on account of the rising prevalence of infectious diseases amongst women, increasing adoption of technologically advanced products, and rising government initiatives. In 2021, Hologic, Inc., a global leader in women's health, acquired Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately US$ 230 million, to strengthen its presence in the women’s health diagnostics market.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
Women Health Diagnostics market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.